Multi-Country Herpes Immunotherapy Clinical Study Continues
WEBMar 5, 2024 · A leading global vaccine developer has announced that their investigational vaccine candidate for Herpes Simplex Virus (HSV) is undergoing a phase 1/2 clinical trial for the first time in Europe, England, and the United States. GlaxoSmithKline plc. (GSK), known for its extensive range of vaccines for various conditions, including RSV, meningitis, and shingles, is conducting an innovative study ...
Herpes Vaccine Candidate Advances in 2023 - Precision …
WEBJanuary 8, 2023 • 3:23 am CST. When BioNTech SE announced that the first person was dosed in a first-in-human Phase 1 clinical trial with BNT163, a herpes simplex virus (HSV) vaccine candidate for the prevention of genital lesions caused by HSV-2 and potentially HSV-1, there was much enthusiasm generated by millions of people.
mRNA-Based Flu Shot Focuses on Improving Performance in …
WEBApr 4, 2024 · As influenza vaccine producers prepare for the 2024 - 2025 flu season, innovative vaccine candidates are progressing in clinical research, focused on enhancing efficacy and safety. CureVac N.V. today announced interim data from an ongoing Phase 2 study, which is part of the combined Phase 1/2 study …
HSV Treatment Readies for Approval - Precision Vaccinations News
WEBMar 29, 2023 · A recently published Original Article reported positive news regarding the First-in-Human clinical trials assessing Pritelivir, a Nonnucleoside Helicase-Primase Inhibitor targeting the Herpes Simplex Virus (HSV). As an active ingredient in a new chemical class (thiazolylamides), Pritelivir is active against both types of …
What’s the Difference Between Shingles and Chickenpox Vaccines?
WEBNov 2, 2017 · Conversely, the Zostavax, the traditional chickenpox vaccine, offers protection against shingles by only 51 percent, and the risk of PHN by 67 percent, according to the CDC. In addition, Zostavax’s effectiveness appears to last just five years, according to the CDC. Like every vaccine, Shingrix has the potential for side effects.
U.S. Government Takes Herpes Vaccine Development Lead
WEBApr 4, 2024 · To address this shortcoming, the U.S. government issued a Notice of Special Interest (NOSI) NOT-AI-24-028 on March 27, 2024, intending to stimulate additional focus on developing diagnostics, therapeutics, and vaccines targeting HSV. This NOSI, issued by the U.S. National Institute of Allergy and Infectious Diseases, focuses on furthering the ...
mRNA Norovirus Vaccine Candidate Launches Phase 3 Clinical Trial
WEB3 days ago · Moderna, Inc. today announced that the first participant in the U.S. has been dosed in the Nova 301 Trial, a pivotal Phase 3 randomized clinical trial evaluating the efficacy, safety, and immunogenicity of an investigational norovirus vaccine, mRNA-1403. As of October 1, 2024, no U.S. FDA-approved norovirus vaccines are available.
34 Countries Identified in the Latest Polio Outbreak Alert
WEBJun 22, 2024 · The Global Polio Eradication Initiative (GPEI) released its weekly update, which indicated that three countries reported new polio cases as the poliovirus continues to spread in 2024. On June 19, 2024, the GPEI reported that Afghanistan confirmed one wild poliovirus type 1 (WPV1), bringing the total number of cases in 2024 to six. Nigeria reported three cases of circulating vaccine-derived ...
Who Brings Measles to the United States? - Precision Vaccinations …
WEBSep 2, 2024 · The U.S. Centers for Disease Control and Prevention (CDC) has repeatedly stated that the majority of measles cases confirmed in the United States are linked to unvaccinated international travelers. This assumption was reaffirmed in late August 2024 when the CDC reported that out of the 236 measles cases this year, 87% were in patients who were either unvaccinated or whose vaccination status ...
Without a Vaccine, Zika Cases Surpass 36,000
WEBSep 24, 2024 · Once the Zika fever outbreak subsided in 2015, many public health agencies refocused on chikungunya and dengue outbreaks. However, continued Zika outbreaks in the Region of the Americas have demonstrated how a relatively obscure mosquito-borne disease can become a persistent health risk. As of September 24, 2024, the Pan American Health Organization (PAHO) reported 36,331 Zika cases this year.
- Some results have been removed